Lehman & Derafelo Financial Resources’s Bionano Genomics BNGO Stock Holding History

Lehman & Derafelo Financial Resources’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23	Closed	-$26K	–	116
2022 Q3	$26K	Hold	23	–	–	0.01%	142
2022 Q2	$19K	Buy	+23	New	+$23.7K	0.01%	153
2021 Q3	–	Sell	-43	Closed	-$189K	–	200
2021 Q2	$189K	Sell	43 -3	-7%	-$11.8K	0.05%	124
2021 Q1	$225K	Sell	46 -13	-22%	-$73.3K	0.06%	110
2020 Q4	$109K	Hold	59	–	–	0.03%	129
2020 Q3	$23K	Hold	59	–	–	0.01%	195
2020 Q2	$18K	Buy	+59	New	+$14.8K	0.01%	194

Other funds holding BNGO

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Lehman & Derafelo Financial Resources's BNGO Position: Q4 2022 in Review

Lehman & Derafelo Financial Resources sold out of Bionano Genomics (BNGO) in Q4 2022, closing a stake of 23 shares — an estimated $26K sold.

Lehman & Derafelo Financial Resources first reported a position in BNGO in Q2 2020 and held it in 7 quarters. The position peaked at $225K in Q1 2021. 143 funds tracked by Wall St. Rank hold BNGO as of Q4 2022.

Lehman & Derafelo Financial Resources reported no remaining Bionano Genomics position as of Q4 2022 after selling out during the quarter.
Lehman & Derafelo Financial Resources sold 23 Bionano Genomics shares in Q4 2022, an estimated $26K.
Lehman & Derafelo Financial Resources first reported a position in Bionano Genomics in Q2 2020 and held it in 7 quarters.
Lehman & Derafelo Financial Resources's Bionano Genomics position peaked at $225K in Q1 2021.
143 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2022.

Based on Lehman & Derafelo Financial Resources's 13F filing for Q4 2022, filed 20 Jan 2023.